News - Page 235 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

Havn Life Sciences announces increase in Bought Deal Financing to $10 Million

Post published:December 15, 2020
Post category:Press Release

Read more about the article Havn Life Sciences announces $5 million Bought Deal Financing

Havn Life Sciences announces $5 million Bought Deal Financing

Post published:December 15, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Enhances Scientific Advisory Board with Appointment of Dr. Charles B. Nemeroff of University of Texas at Austin

Silo Pharma, Inc. Enhances Scientific Advisory Board with Appointment of Dr. Charles B. Nemeroff of University of Texas at Austin

Post published:December 15, 2020
Post category:Press Release

Read more about the article Red Light Holland Commences Growing 1,000,000 Grams of Magic Truffles

Red Light Holland Commences Growing 1,000,000 Grams of Magic Truffles

Post published:December 15, 2020
Post category:Press Release

Read more about the article Pharmadrug Provides Corporate Update and Balance Sheet Status

Pharmadrug Provides Corporate Update and Balance Sheet Status

Post published:December 15, 2020
Post category:Press Release

Read more about the article Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

Post published:December 15, 2020
Post category:Press Release

Read more about the article PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders

PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders

Post published:December 15, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

Post published:December 15, 2020
Post category:Press Release

Read more about the article Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom

Psyched Wellness Successfully Completes Extraction of a Legal Psychedelic Mushroom

Post published:December 15, 2020
Post category:Press Release

Read more about the article Havn Life Sciences Undertakes One of the First Preclinical Studies on Psilocybin and the Immune System

Havn Life Sciences Undertakes One of the First Preclinical Studies on Psilocybin and the Immune System

Post published:December 15, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.